Cytori Reports Q2 2018 Business and Financial Results
SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced Q2 2018 financial results and provided updates on corporate activities. Q2 2018 net loss was $3.7 million, or $0.59 per share. …